DXR stock forecast
Our latest prediction for Daxor Corp.'s stock price was made on the March 21, 2019 when the stock price was at 12.34$.
In the short term (2weeks), DXR's stock price should outperform the market by 3.69%. During that period the price should oscillate between -9.48% and +17.65%.
In the medium term (3months), DXR's stock price should underperform the market by -0.76%. During that period the price should oscillate between -20.11% and +35.90%.Get email alerts
About Daxor Corp.
Daxor Corp. is a biotechnology company which develops and manufactures BVA-100 blood volume analyzer, an instrument that measures human blood volume. Its IDANT division provides autologous blood storage; and andrology services, such as semen analysis, sperm washing and general lab testing. The company was founded by Joseph Feldschuh in 1970 and is headquartered in New York, NY.
At the moment the company generates -1M USD in revenues.
On its last earning announcement, the company reported a loss of -0.19$ per share.
The book value per share is 3.69$
Three months stock forecastMarch 21, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|